)
Ovid Therapeutics (OVID) investor relations material
Ovid Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting commenced at 10:30 A.M. on June 10, 2026, via a virtual platform, with introductions of key executives and auditors.
The agenda included three proposals: election of a director, advisory vote on executive compensation, and ratification of the auditor.
Voting procedures and meeting conduct rules were explained, with polls opened for voting.
Board and executive committee updates
Jeremy M. Levin was nominated for election as Class III director to serve until the 2029 annual meeting.
Shareholder proposals
Three proposals were presented: election of a director, advisory approval of executive compensation, and ratification of KPMG as auditor for 2026.
- Pipeline progress, strong safety, and financing extend cash runway into late 2028 or 2029.OVID
Q4 202515 May 2026 - Net loss was $17.0M in Q1 2026; cash reserves and funding extend runway into 2029.OVID
Q1 202612 May 2026 - Advancing novel therapies for seizures and psychosis with strong safety and market potential.OVID
Corporate presentation12 May 2026 - Director election, say-on-pay, auditor ratification, and governance updates headline the 2026 proxy.OVID
Proxy filing27 Apr 2026 - Vote on director election, executive pay, and auditor ratification at the June 2026 meeting.OVID
Proxy filing27 Apr 2026 - OV4071 advances as a first-in-class oral KCC2 activator for broad, safe psychosis treatment.OVID
Status update26 Apr 2026 - Registering 29.9M shares for resale after $60M private placement; no resale proceeds to company.OVID
Registration filing22 Apr 2026 - OV329 and OV4071 advance in clinical trials, targeting epilepsy and CNS disorders.OVID
Leerink Global Healthcare Conference 202611 Mar 2026 - OV329 and OV4071 advance in CNS disorders, with major clinical data expected within 18 months.OVID
TD Cowen 46th Annual Health Care Conference4 Mar 2026
Next Ovid Therapeutics earnings date
Next Ovid Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage